Key Highlights :
1. Telangana is emerging as a life sciences hub, with global and domestic pharmaceutical firms expanding or setting up facilities in the city.
2. The city has secured over $700 million in investments within the past year and is projected to reach $250 billion by 2030.
3. Hyderabad is the only city in India expanding its life science park—Genome Valley, Medtech Park, and the upcoming world's largest, Pharma City.
4. Currently, 4 of the top 10 global innovator companies—Novartis, BMS, Sanofi, and Roche—have a direct presence in Hyderabad through their dedicated centres.
5. Yapan Bio has grown significantly since its establishment in Genome Valley, Hyderabad, in 2019.
6. Genome Valley provides an opportunity for young companies to establish and grow while staying asset-light so that the capital can be utilised for core R&D activities rather than infrastructure setup.
7. As a services-focused startup, being a part of this cluster helps access ready infrastructure, potential partners, and scientific talent, which are critical for the success and growth of any organisation.
8. Hyderabad, is a hub for the pharmaceutical, vaccine, and biotechnology sectors, hosting top players at the forefront of innovation and attracting investments of more than $3 billion from companies such as Novartis, BMS, Sanofi, and Roche, which have generated over 450,000 jobs in the last seven years.
9. Telangana IT and Industries Minister K.T. Rama Rao aims to position the city as the "Health-Tech Mecca" of the world.
10. The increasing government spending on healthcare and cost benefits such as affordable human resources, lower real estate expenses compared to other global markets, and growing biotech startups are seen as critical catalysts of growth for India's life science sector, according to industry experts.
The Government of Telangana is committed to providing an inspiring ecosystem for the growth of the life sciences industry as illustrated by the ambitious target for the life sciences ecosystem in the region to reach $ 250 billion by 2030. To achieve this, we are actively working towards creating world-class infrastructure, promoting research and development, and providing a skilled workforce to accelerate innovation.
We have a number of initiatives in place to support the growth of the life sciences industry in Telangana. These include the establishment of the Telangana Life Sciences University (TLSU), which will provide world-class education and research facilities in the life sciences sector; the establishment of the Telangana State Industrial Infrastructure Development Corporation (TSIDC), which will develop industrial infrastructure in the state; and the establishment of the Telangana State Innovation Foundation (TSIF), which will promote innovation in the life sciences sector.
We are also working to improve the infrastructure and environment for the growth of the life sciences industry in the state. For example, we are constructing a world-class biotechnology park in Warangal, which will provide facilities for the research and development of biotechnology products. We are also developing a world-class cancer research center in Hyderabad, which will provide facilities for the research and treatment of cancer patients.
We are committed to providing an inspiring ecosystem for the growth of the life sciences industry in Telangana, and we are confident that we can achieve our ambitious target of $ 250 billion by 2030.
